Alogliptin (Benzoate) - CAS# 850649-62-6 683 DUN09716 (0-100 μM) shows strong

DUN09716 (0-100 μM) shows strong inhibition selectivity in NSCLC cells with IC50s ranging from 39

The mechanism-of-action of CPI-613 appears distinct from the current classes of anti-cancer agents used in the clinic

small molecule modulators of IRE1α

EW-7197 Hydrochloride

[Pharmacokinetics and disposition of triptonide in rats]

Alogliptin (Benzoate) - CAS# 850649-62-6 683 DUN09716 (0-100 μM) shows strongAlogliptin benzoate is a DPP 4 inhibitor used for the treatment of Type 2 diabetes. Like other members of the gliptin class, it causes little or no weight gain, exhibits relatively little risk of causing hypoglycemia, and exhibits relatively modest glucose lowering activity. Alogliptin and other gliptins are commonly used in combination with metformin in patients whose diabetes cannot adequately be controlled with metformin alone. Product information